VIDEO

FindCenter AddIcon

Pioneers in Psychedelic Research: Rabbi Zalman Schachter-Shalomi (1998)

By Zalman Schachter-Shalomi — 2020

Rabbi Zalman Schachter-Shalomi (1924-2014) interviewed on his life and early psychedelic research, in his first home in Boulder, Colorado, 1998. Produced in conjunction with the Fetzer Institute and the Gathering of Elders Conference.

01:34:15 min

For the Inward Journey

The essence of Dr. Howard Thurman (1900–1981) and his thought emerges in a message of hope, reconciliation, and love.

Book
Howard Thurman
1984
FindCenter AddIcon

Howard Thurman: Essential Writings

Howard Thurman, minister, philosopher, civil rights activist, has been called ‘one of the greatest spiritual resources of this nation.’ His encounters with Gandhi in India helped instill his commitment to nonviolence. This book features some of his writings.

Book
Howard Thurman
2006
FindCenter AddIcon

CIA Exploited Incarcerated Black Americans in Race for “Mind-Control” Agent

A well-kept American secret is that the CIA-funded research that exploited incarcerated Black Americans along with other vulnerable groups in America’s hunt for a “mind-control” drug.

Article
Dana Strauss, Monnica Williams
2021
FindCenter AddIcon

The Cost of Exclusion in Psychedelic Research

In the last two decades, researchers have started to reexamine psychedelics for their therapeutic potential. Though initial results seem promising, the research has a significant shortcoming: the lack of racial and ethnic diversity among research teams and study participants.

Article
Xinyuan Chen, Mackenzie Bullard, Christy Duan, Jamilah R. George, Terence Ching, Stephanie Kilpatrick, Jordan Sloshower, Monnica Williams
2020
FindCenter AddIcon

Psychedelic Psychotherapy Is Coming: Who Will Be Included?

A new study finds widespread exclusion of minorities in psychedelic research.

Article
Monnica T. Williams
2018
FindCenter AddIcon

How Researchers and Advocates of Color Are Forging Their Own Paths in Psychedelic-Assisted Therapy

We’re seeing an explosion of medical research into psychedelics. Psilocybin, or shrooms, to treat major depressive disorder. Ayahuasca, a psychotropic plant medicine from the Amazon, and ibogaine, a potent hallucinogen from Africa, to treat addiction. LSD for anxiety.

Article
Steph Yin
2020
FindCenter AddIcon

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

Article
Hannah Sabourin
2021
FindCenter AddIcon

Psychedelics Shown to Ease the Effects of Racial Trauma

A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).

Article
Kristi Pahr
2021
FindCenter AddIcon

EXPLORE TOPIC

Altered States of Consciousness